Literature DB >> 3108332

Control of oral anticoagulant treatment by chromogenic prothrombin assay.

J R O'Donnell, I D Walker, J F Davidson.   

Abstract

Doses of oral anticoagulants in 50 patients on long term treatment were easily and satisfactorily monitored over six months by an automated chromogenic assay of prothrombin (CPA). It is suggested that chromogenic assay of one or more of the vitamin K dependent coagulation factors would provide a readily standardised alternative to those conventional tests which depend on human brain derived reagents, now regarded as a biohazard.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3108332      PMCID： PMC1141011          DOI： 10.1136/jcp.40.5.500

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


  15 in total

1.  A new era in the laboratory evaluation of coagulation and fibrinolysis.

Authors:  H Stormorken
Journal:  Thromb Haemost       Date:  1976-11-30       Impact factor: 5.249

2.  Turnover of prothrombin, factor VII and factor IX in a patient with hemophilia A.

Authors:  P F HJORT; O EGEBERG; S MIKKELSEN
Journal:  Scand J Clin Lab Invest       Date:  1961       Impact factor: 1.713

3.  Incorrect least-squares regression coefficients in method-comparison analysis.

Authors:  P J Cornbleet; N Gochman
Journal:  Clin Chem       Date:  1979-03       Impact factor: 8.327

4.  Determination of plasma prothrombin with a reaction rate analyzer using a synthetic substrate.

Authors:  K Bergström; M Blombäck
Journal:  Thromb Res       Date:  1974-06       Impact factor: 3.944

5.  Standardisation of oral anticoagulant treatment.

Authors:  N K Shinton
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-08

6.  Questions and answers on prothrombin time standardisation in oral anticoagulant control.

Authors:  E A Loeliger; L Poller; M Samama; J M Thomson; A M Van den Besselaar; J Vermylen; M Verstraete
Journal:  Thromb Haemost       Date:  1985-08-30       Impact factor: 5.249

7.  Maintenance control of oral anticoagulant therapy by a chromogenic substrate assay for factor X.

Authors:  J G Erskine; I D Walker; J F Davidson
Journal:  J Clin Pathol       Date:  1980-05       Impact factor: 3.411

8.  Newer synthetic peptide substrates in coagulation testing: some practical considerations for automated methods.

Authors:  L G Svendsen; J Fareed; J M Walenga; D Hoppensteadt
Journal:  Semin Thromb Hemost       Date:  1983-10       Impact factor: 4.180

9.  Use of chromogenic peptide substrates in the determination of clotting factors II, VII, IX and X in normal plasma and in plasma of patients treated with oral anticoagulants.

Authors:  M P van Dieijen-Visser; J van Wersch; P J Brombacher; J Rosing; H C Hemker; G van Dieijen
Journal:  Haemostasis       Date:  1982

10.  Prothrombin determination by means of a chromogenic peptide substrate.

Authors:  G Axelsson; K Korsan-Bengtsen; J Waldenström
Journal:  Thromb Haemost       Date:  1976-12-31       Impact factor: 5.249
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.